Perceptive Advisors »

Autolus Therapeutics Plc spon ads shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 1.8M 6.44

More positions owned by Perceptive Advisors

Cerevel Therapeutics Hldng I (CERE)
Amicus Therapeutics (FOLD)
Lianbio Sponsored Ads (LIANY)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Inhibrx (INBX)
Soleno Therapeutics (SLNO)
Rhythm Pharmaceuticals (RYTM)
Immunovant (IMVT)
Iovance Biotherapeutics (IOVA)
Cymabay Therapeutics
Axsome Therapeutics (AXSM)
Medtronic SHS (MDT)
Cargo Therapeutics (CRGX)
Meiragtx Holdings (MGTX)

View all positions for Perceptive Advisors

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads